Patient Decision Aids Linked to Improved Perception of Medical Knowledge in Cancer Survivors

Share this content:

the Cancer Therapy Advisor take:

Patients from a patient decision aid (P-DA) trial reported increased knowledge and decision-making confidence compared to those with usual care alone, according to an article published online in the journal Cancer.

Patients with early-stage thyroid cancer at a Canadian tertiary/quaternary care center were contacted 15 to 23 months after randomization and radioactive iodine (RAI) decision-making to examine long-term outcomes.

Of the original 74 patients, 70 (95%) of them enrolled in follow-up at a mean of 17.1 months after randomization. 

Results showed patients who used P-DA reported being significantly more informed about the treatment choice, aware of their options, knowledgeable about treatment benefits, and knowledgeable about risks and side effects associated with treatment (P=0.008, P =0.009, P =0.020, and P=0.001, respectively).

No significant differences were observed between the two groups in regards to decision satisfaction (P=0.142), decision regret (P=0 .199), cancer-related worry (P=0 .645), mood (P=0.211), or physician trust (P=0.764).

Patients from a patient decision aid trial reported increased knowledge and decision-making confiden
Patients from a patient decision aid trial reported increased knowledge and decision-making confidence.
Sawka, A. M., Straus, S., Rodin, G., Heus, L., Brierley, J. D., Tsang, R. W., Rotstein, L., Ezzat, S., Segal, P., Gafni, A., Thorpe, K. E. and Goldstein, D. P. (2015), Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial. Cancer. doi: 10.1002/cncr.29548
READ FULL ARTICLE From Wiley Online Library

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters